(Q83265675)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19180076%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

A C. elegans-based, whole animal, in vivo screen for the identification of antifungal compounds (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19180076%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

main subject

Caenorhabditis elegans

1 reference

based on heuristic

inferred from title

author

Eleftherios Mylonakis

series ordinal

3

object named as

Eleftherios Mylonakis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19180076%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Emmanouil Tampakakis

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19180076%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Ikechukwu Okoli

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19180076%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19180076%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19180076%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19180076%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19180076%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

1925-1931

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19180076%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nprot.2008.193

20 January 2020

exact match

0 references

cites work

New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.193

Burden of hospitalization of patients with Candida and Aspergillus infections in Australia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.193

Candida Albicans: a molecular revolution built on lessons from budding yeast

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.193

The impact of candidemia on length of hospital stay, outcome, and overall cost of illness.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.193

An update on antifungal targets and mechanisms of resistance in Candida albicans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.193

Evolution of antifungal-drug resistance: mechanisms and pathogen fitness

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.193

Characterization of mediators of microbial virulence and innate immunity using the Caenorhabditis elegans host-pathogen model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.193

Exploiting amoeboid and non-vertebrate animal model systems to study the virulence of human pathogenic fungi

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.193

The worm has turned--microbial virulence modeled in Caenorhabditis elegans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.193

Antifungal chemical compounds identified using a C. elegans pathogenicity assay

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.193

Contributions of hyphae and hypha-co-regulated genes to Candida albicans virulence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.193

Nonfilamentous C. albicans mutants are avirulent

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.193

Candida biofilms and their role in infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.193

Galleria mellonella as a model host to study infection by the Francisella tularensis live vaccine strain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.193

Developing insect models for the study of current and emerging human pathogens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.193

Identification of novel antimicrobials using a live-animal infection model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.193

Finding function in novel targets: C. elegans as a model organism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.193

Caenorhabditis elegans: a versatile platform for drug discovery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.193

The worm turns for antimicrobial discovery.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.193

Infection in a dish: high-throughput analyses of bacterial pathogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.193

Interactions with microbial pathogens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.193

Worms and flies as genetically tractable animal models to study host-pathogen interactions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.193

Using nematodes in soil ecotoxicology.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.193

A conserved p38 MAP kinase pathway in Caenorhabditis elegans innate immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.193

Candida albicans biofilm-defective mutants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.193